Taxane Market: Can a Three-Decade-Old Chemotherapy Class Still...

أضاف وظيفة جديدة Health

2026-07-22 09:27:31 -

Taxane Market: Can a Three-Decade-Old Chemotherapy Class Still Compete With Targeted Cancer Therapies?

The taxane market — a class of microtubule-stabilizing chemotherapy drugs including paclitaxel, docetaxel, and cabazitaxel, derived originally from yew tree compounds and used across breast, lung, ovarian, and prostate cancer treatment — continues to demonstrate resilient, steady growth despite the broader oncology industry's shift toward targeted therapies and immunotherapy, with...

0 التعليقات 0 المشاركات 9 مشاهدة 0 معاينة